People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotech, Biotechnology, Other Health Care, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | — | Biotech | Series D+ | $303.3M | $6.0B | 2020 |
| Vizgen, Inc. | — | Biotechnology | Series D+ | $295.1M | $320.2M | 2024 |
| DermTech, Inc. | — | Other Health Care | Series C | $98.9M | $1.5B | 2020 |
| General Automation Lab Technologies Inc. | — | Software / Tech | Series A | $38.5M | $338.0M | 2019 |
Matthew Posard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Posard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrea Jackson | 2 | 6 |
| PAUL CONLEY | 1 | 17 |
| Keith Crandell | 1 | 11 |
| Gary Jacobs | 1 | 11 |
| Vijay Pande | 1 | 9 |
| Stuart Nagae | 1 | 9 |
| Michael Rubin | 1 | 8 |
| Enrico Picozza | 1 | 7 |
| David Walt | 1 | 6 |
| Paxton Major | 1 | 5 |
| Gene Salkind | 1 | 5 |
| Michael Willis | 1 | 4 |
| Robert Carson | 1 | 3 |
| MATTHEW S. MCILWAIN | 1 | 3 |
| Michael Altman | 1 | 3 |
| Farzad Nazem | 1 | 2 |
| Marijn E. Dekkers | 1 | 2 |
| Sujal Patel | 1 | 2 |
| Kevin Sun | 1 | 2 |
| Burkhard Jansen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.